[ABCL] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[ABCL] AbCellera Biologics Inc.
Announcement Date
25-Feb-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- 380.39%
YoY- -48.76%
Quarter Report
ABCL's Result
ABCL's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 101,383 45,917 316,581 139,331 5,508 27,643 202,741 -36.97%
PBT 46,587 -6,886 230,809 84,710 -24,972 -2,073 161,487 -56.30%
Tax 19,963 -101 62,236 24,762 -3,592 250 44,266 -41.16%
NP 26,624 -6,785 168,573 59,948 -21,380 -2,323 117,221 -62.74%
Tax Rate -42.85% - -26.96% -29.23% - - -27.41% -
Total Cost 74,759 52,702 148,008 79,383 26,888 29,966 85,520 -8.56%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin 26.26 -14.78 53.25 43.03 -388.16 -8.40 57.82 -40.88%
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS 0.08 -0.02 0.54 0.21 -0.08 -0.01 0.43 -67.37%
EPS Diluted 0.08 -0.02 0.54 0.21 -0.08 -0.01 0.37 -63.94%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.